Mechanism of stereoselective serum binding of ketoprofen after hemodialysis

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 2, 1996, Pages 786-792

  Sakai, Toshiaki ^b   Maruyama, Toru ^b   Imamura, Hitoshi ^b   Shimada, Hidekata ^b   Otagiri, Masaki ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

KETOPROFEN; SERUM ALBUMIN; UREMIC TOXIN;

ADULT; ALLOSTERISM; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG CONFORMATION; DRUG METABOLISM; DRUG PROTEIN BINDING; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; STEREOCHEMISTRY;

ADULT; CARRIER PROTEINS; FATTY ACIDS; HUMANS; KETOPROFEN; KINETICS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RENAL DIALYSIS;

EID: 0030425577     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BIRKETT, D. J., MYERS, S. P. AND HAGEDORN, J.: Effect of fatty acids on the binding of drugs and bilirubin to human serum albumin. Adv. Pharmacol. Ther. 7: 125-134, 1979.
2. BOPP, R. J., NASH, J. F., RIDOLFO, A. S. AND SHEPARD, E. D.: Stereoselective inversion of (R)-(-)-benoxaprofen to the (S)-(+)-enantiomer in humans. Drug Metab. Dispos. 7: 356-359, 1979.
3. CARTER, D. C. AND HO, J. X.: Structure of serum albumin. Adv. Pro. Chem. 45: 153-203, 1994.
4. DUBOIS, N., LAPICQUE, F., ABITEBOUL, M. AND NETTER, P.: Stereoselective protein binding of ketoprofen. Chirality 5: 126-134, 1993.
5. GULYASSY, P. F. AND DEPNER, T. A.: Impaired binding of drugs and endogenous ligands in renal diseases. Am. J. Kidney Dis. 2: 578-601, 1983.
6. HAYBALL, P. J., NATION, R. L., BOCHNER, F., SANSOM, L. N., AHERN, M. J. AND SMITH, M. D.: The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis. Br. J. Clin. Pharmacol. 36: 185-193, 1993.
7. HENDERSON, S. J. AND LINDUP, W. E.: Interaction of 3-carboxy-4-methyl-5-propyl-2-furan propanoic acid, an inhibitor of plasma protein binding in uremia, with human albumin. Biochem. Pharmacol. 40: 2543-2548, 1990.
8. JAMALI, F.: Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs. Eur. J. Clin. Pharmacol. 13: 1-9, 1988.
9. JAMALI, F. AND BROCKS, D. R.: Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin. Pharmacokinet. 19: 197-217, 1990.
10. JONES, M. E., SALLUSTIO, B. C., PURDIE, Y. J. AND MEFFIN, P. J.: Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs. II. 2-Phenyl propionic acid binding. J. Pharmacol. Exp. Ther. 238: 288-294, 1986.
11. KNADLER, M. R., BRATER, D. C. AND HALL, S. D.: Plasma protein binding of flurbiprofen: Enantioselectivity and influence of pathophysiological status. J. Pharmacol. Exp. Ther. 249: 378-385, 1989.
12. KRAGH-HANSEN, U.: Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33: 17-53, 1981.
13. LAPICQUE, F., MULLER, N., PAYAN, E., DUBOIS, N. AND NETTER, P.: Protein binding and stereoselectivity of nonsteroidal anti-inflammatory drugs. Clin. Pharmacokinet. 25: 115-125, 1993.
14. LIM, C. F., BERNARD, B. F., DE JONG, M., DOCTER, R., KRENNING, E. P. AND HENNEMANN, G.: A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia. J. Clin. Endocrinol. Metab. 76: 318-324, 1993(a).
15. LIM, C. F., STOCKIGT, J. R., CURTIS, A. J., WYNNE, K. N., BARLOW, J. W. AND TOPLISS, D. J.: A naturally occurring furan fatty acid enhances drug inhibition of thyroxine binding in serum. Metabolism 42: 1468-1474, 1993(b).
16. LIN, J. H., COCCHETTO, D. M. AND DUGGAN, D. E.: Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs. Clin. Pharmacokinet. 12: 402-432, 1987.
17. LINDUP, W. E.: Plasma protein binding of drugs-some basic and clinical aspects. In Progress in Drug Metabolism vol. 10 ed. by J. W. Bridges, L. F. Chasseaud and C. G. Gibson, pp. 141-185, Taylor and Francis, 1987.
18. LINDUP, W. E., HENDERSON, S. J. AND BARKER, C. E.: Drug binding in renal disease. In Plasma Binding of Drug and Its Consequence, ed. by F. Belpaire, M. Bogaert, J. P. Tillement and E. Verbeeck, pp. 103-120, Academic Press, Ghent, 1991.
19. MCNAMARA, P. J., TRUEB, V. AND STOECKEL, K.: Cefriaxone binding to human serum albumin: Indirect displacement by probenecid and diazepam. Biochem. Pharmacol. 40: 1247-1253, 1990.
20. MURRAY, M. D. AND BRATER, D. C.: Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu. Rev. Pharmacol. Toxicol. 32: 435-465, 1993.
21. NARANJO, C. A. AND SELLERS, E. M.: Fatty acids modulation of drug binding to plasma proteins. In Drug-Protein Binding, ed. by M. M. Reidenberg and S. Erill, pp. 233-251, Praeger Scientific, New York, 1986.
22. RAHMAN, M. H., YAMASAKI, K., SHIN, Y-H., LIN, C. C. AND OTAGIRI, M.: Characterization of high affinity binding sites of non-steroidal anti-inflammatory drugs with respect to site-specific probes on human serum albumin. Biol. Pharm. Bull. 6: 1169-1174, 1993.
23. SAKAI, T., TAKADATE, A. AND OTAGIRI, M.: Characterization for binding site of uremic toxins on human serum albumin. Biol. Pharm. Bull. 18: 1755-1761, 1995.
24. SJÖHOLM, I., EKMAN, B., KOBER, A., LJUNGSTEDT-PÄLMAN, I., SEIVING, B. AND SJÖDIN, T.: Binding of drugs to human serum albumin. Mol. Pharmacol. 16: 767-777, 1979.
25. SJÖHOLM, I., KOBER, A., ODAR-CEDERLÖF, I. AND BOAGA, O.: Protein binding of drug in uremic and normal serum: The role of endogenous binding inhibitors. Biochem. Pharmacol. 25: 1205-1213, 1976.
26. WANWIMOLRUK, S., BIRKETT, D. J. AND BROOKS, P. M.: Structural requirements for drug binding to site II on human serum albumin. Mol. Pharmacol. 24: 458-463, 1983.
27. WILTING, J., VAN DER GIESEN, W. F., JANSSEN, L. H. M., WEIDEMAN, M. M., OTAGIRI, M. AND PERRIN, J. H.: Effect of albumin conformation on the binding of warfarin to human serum albumin: Dependence of the binding of warfarin to human serum albumin on the hydrogen, calcium and chloride ion concentrations as studied by circular dichroism, fluorescence and equilibrium dialysis. J. Biol. Chem. 255: 3032-3037, 1980.
28. YAMAOKA, K., TANIGAWARA, Y., NAKAGAWA, T. AND UNO, T.: A pharmacokinetic analysis program (MULTI) for micro-computer. J. Pharmacobio-Dyn. 4: 879-885, 1981.